FDA warns of severe itching linked to common allergy medications
NEW YORK, May 27: The US Food and Drug Administration (FDA) has issued a warning regarding a rare but troubling side effect experienced by some individuals who stop taking certain over-the-counter allergy medications such as Zyrtec and Xyzal.
According to the FDA, hundreds of people reported experiencing severe, widespread itching — medically known as pruritus — after discontinuing medications containing cetirizine or levocetirizine, the active ingredients in Zyrtec and Xyzal, respectively. The issue was significant enough in some cases to require medical treatment.
'These reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical intervention,' the FDA stated in its warning. Some individuals described the itching as so intense that it negatively affected their quality of life and ability to function.
Between 2017 and 2023, the FDA identified approximately 200 cases of post-discontinuation itching. Most of those affected had been using the medications daily for three months or longer, only to develop symptoms after stopping their use.
Cetirizine is sold under several brand names including Zyrtec, Aller-Tec, and All Day Allergy, while levocetirizine is best known as Xyzal. Both are antihistamines commonly used to treat seasonal allergies, and are available in both prescription and non-prescription forms.
In most instances, patients found relief by restarting the medication or by tapering off more gradually rather than stopping abruptly.
While the number of affected individuals is relatively small compared to the tens of millions who use these drugs annually, the FDA is taking action. The agency announced it will revise the labeling of cetirizine and levocetirizine products to include a warning about this potential side effect.
Despite the concern, health officials emphasize that the risk remains low and that these medications are generally safe for most users. However, they encourage individuals to speak with a healthcare provider if they experience unusual symptoms after discontinuing allergy medication.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arab Times
27-05-2025
- Arab Times
FDA warns of severe itching linked to common allergy medications
NEW YORK, May 27: The US Food and Drug Administration (FDA) has issued a warning regarding a rare but troubling side effect experienced by some individuals who stop taking certain over-the-counter allergy medications such as Zyrtec and Xyzal. According to the FDA, hundreds of people reported experiencing severe, widespread itching — medically known as pruritus — after discontinuing medications containing cetirizine or levocetirizine, the active ingredients in Zyrtec and Xyzal, respectively. The issue was significant enough in some cases to require medical treatment. 'These reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical intervention,' the FDA stated in its warning. Some individuals described the itching as so intense that it negatively affected their quality of life and ability to function. Between 2017 and 2023, the FDA identified approximately 200 cases of post-discontinuation itching. Most of those affected had been using the medications daily for three months or longer, only to develop symptoms after stopping their use. Cetirizine is sold under several brand names including Zyrtec, Aller-Tec, and All Day Allergy, while levocetirizine is best known as Xyzal. Both are antihistamines commonly used to treat seasonal allergies, and are available in both prescription and non-prescription forms. In most instances, patients found relief by restarting the medication or by tapering off more gradually rather than stopping abruptly. While the number of affected individuals is relatively small compared to the tens of millions who use these drugs annually, the FDA is taking action. The agency announced it will revise the labeling of cetirizine and levocetirizine products to include a warning about this potential side effect. Despite the concern, health officials emphasize that the risk remains low and that these medications are generally safe for most users. However, they encourage individuals to speak with a healthcare provider if they experience unusual symptoms after discontinuing allergy medication.
Arab Times
15-04-2025
- Arab Times
Fake Ozempic hits the US market — here's how to spot it
WASHINGTON, April 15: The US Food and Drug Administration (FDA) on Monday urged patients and healthcare providers to verify the authenticity of their Ozempic prescriptions after the agency confiscated several hundred counterfeit units of the popular diabetes drug in the U.S. According to a news release from the FDA, pharmaceutical company Novo Nordisk — which manufactures Ozempic and the weight loss drug Wegovy — alerted the agency on April 3 that 1-milligram doses of counterfeit Ozempic injections were being distributed outside of the company's authorized supply chain. This indicates the products likely entered the market through unauthorized distributors or resellers. On April 9, the FDA seized the counterfeit injections, which are labeled with lot number PAR0362 and serial numbers beginning with 51746517. The agency also noted that it has received six reports of adverse events linked to this lot. However, none of those incidents appear to be directly associated with the counterfeit product. Both the FDA and Novo Nordisk are currently testing the seized products to assess their contents and determine potential safety concerns. Since even genuine Ozempic can cause side effects such as gastrointestinal issues, it remains unclear if the reported adverse events stemmed from typical use or the fake products. The discovery highlights the increasing demand for Ozempic, which, while developed to treat type 2 diabetes, has surged in popularity for its off-label use in weight loss. Similar glucagon-like peptide-1 (GLP-1) drugs have also seen a rise in demand. This isn't the first counterfeit seizure involving the drug. In December 2023, the FDA announced it had seized thousands of fake Ozempic units and warned that some may still be circulating in the market. These fake injections are distinct from compounded versions of semaglutide, which are permitted under FDA rules in certain circumstances — particularly during shortages. However, in February, the FDA declared that shortages of Ozempic and Wegovy had been resolved in the U.S., effectively curbing the legal production and sale of compounded alternatives. The FDA continues to advise consumers and healthcare professionals to obtain medications through legitimate, authorized channels and to report any suspected counterfeit products.
Arab Times
15-03-2025
- Arab Times
FDA warns of misuse of laughing gas sold in colorful, flavored canisters
WASHINGTON, March 15, (AP): US health officials are tracking a rise in injuries tied to the misuse of nitrous oxide, or laughing gas, including some brands that are sold in small canisters containing flavors like blueberry, strawberry and watermelon. The Food and Drug Administration on Friday warned consumers that inhaling the gas for its euphoric effects can cause dangerously low blood pressure, leading to loss of consciousness and injuries. The agency flagged a number products sold in colorful packaging at gas stations, vape shops and online including Cosmic Gas, Galaxy Gas and MassGass. Nitrous gas is traditionally used as a sedative for patients in dental offices and hospitals. It's also found in pressurized cans of whipped cream. But teens and adults have long misused those products to get high. The gas can briefly disrupt oxygen flow to the brain. Companies selling the products cited by regulators advertise them "for culinary use only' and often include disclaimers on their websites warning against inhaling. But videos of young people using the products recreationally have circulated on social media platforms for years. The FDA said it has seen "an increase in reports of adverse events' with nitrous products. And poison control centers have also reported emergency calls from people who had to be rushed to the hospital after collapsing while misusing the products. There are no federal limits on who can purchase nitrous oxide, although some states have passed minimum age requirements. The FDA regulates the gas as a medical product when used by doctors and dentists, although it's unclear how much oversight it would have of products marketed for culinary use.
